For a better experience, Read this story in our App
TO ENJOY ADDITIONAL BENEFITS
Connect With Us
Get BusinessLine apps on
FILE PHOTO: Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy. | Photo Credit: Hollie Adams
Danish company Novo Nordisk has launched Wegovy for weight loss, in India on Tuesday.
The injectable product, called the “skinny jab” by some, contains semaglutide - the active ingredient present in diabetes product Ozempic, as well. Both products became popular globally, as celebrities took the product for weight loss.
The delivery device is a 4-dose pen that comes at a price of ₹17,345 for a month for lower strengths (starting 0.25 mg), going up to ₹26,050 for higher strength of 2.4 mg.
Vikrant Shrotriya, Corporate Vice President and MD, Novo Nordisk India speaking at the launch of Wegovy in India.
A key patent on Semaglutide expires in some markets, early 2026. In India, several generics wait in the wings, to bring in their product, even as Novo has an ongoing patent infringement suit with local companies Dr Reddy’s Laboratories and OnceSource on the product.
Vikrant Shrotriya, Corporate Vice President and MD, Novo Nordisk India speaking at the launch of Wegovy in India.
About three months ago, Eli Lilly launched its Mounjaro in India. This is a once-a-week, prescription-based injectable that reduces food intake and body weight, besides decreasing fat mass by regulating appetite.
Published on June 24, 2025
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.